Stock

Dogwood Therapeutics, Inc. DWTX

$1.56+4.00%

All stocks Create account to unlock

Overview

DWTX market data

Price History

DWTX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for DWTX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

6 captured

Dogwood Therapeutics Admits First 200 Participants In Its Current HAL-CINP Phase 2b Study To Evaluate Efficacy, Safety Of Halneuron · Jul 20, 2026, 12:34 PM

8-K filing — Dogwood Therapeutics, Inc. (DWTX) · Jun 17, 2026, 8:55 PM

Dogwood Therapeutics Starts New Halneuron Hemotherapy Induced Neuropathic Pain Phase 2b Extension Trial · May 18, 2026, 12:50 PM

Dogwood Therapeutics Announces Worldwide Development And Commercialization Partnership For Legacy Antiviral Assets · May 14, 2026, 12:45 PM

Dogwood Therapeutics Q1 EPS $(0.15), Inline · May 14, 2026, 12:31 PM

Earnings Scheduled For May 14, 2026 · May 14, 2026, 11:11 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock